8-Azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents

Details for Australian Patent Application No. 2004245490 (hide)

Owner Allergan, Inc.

Inventors Dinh, Thang D.; Old, David W.; Burk, Robert M.

Agent Davies Collison Cave

Pub. Number AU-A-2004245490

PCT Pub. Number WO2004/108669

Priority 10/453,818 02.06.03 US

Filing date 25 May 2004

Wipo publication date 16 December 2004

International Classifications

C07D 207/26 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/108669 Priority application(s): WO2004/108669

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004245492-3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure

2004245489